| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Outcomes |



* Department of Medicine,
Department of Pathology, and
Research Center, Ramathibodi Hospital, Mahidol University, Bangkok; and
Electricity Generating Authority of Thailand, Bangkok, Thailand
Address correspondence to: Dr. Somnuek Domrongkitchaiporn, Department of Medicine, Ramathibodi Hospital, Rama 6 Road, Bangkok 10400, Thailand. Phone: 662-201-1116; Fax: 662-246-2123; E-mail: rasdr{at}mahidol.ac.th
End-stage kidney disease has become an increasing burden in all regions of the world. However, limited epidemiologic data on chronic kidney disease in Southeast Asian populations are available. Therefore, a cohort study over a period of 12 yr (1985 to 1997) in 3499 employees of the Electric Generation Authority of Thailand, aged 35 to 55 yr, was conducted to determine the prevalence of decreased kidney function and risk factors associated with future development of decreased kidney function. The prevalence of decreased kidney function (GFR <60 ml/min) increased from 1.7% (95% confidence interval [CI], 1.3 to 2.1) in 1985 to 6.8% (95% CI, 5.7 to 7.9) in 1997, and the prevalence of elevated serum creatinine was 6.1% (95% CI, 5.3 to 6.9) and 16.9% (95% CI, 15.3 to 18.5) in 1985 and 1997 surveys, respectively. The adjusted odds ratio for future development of decreased kidney function was 2.57 (1.0 to 6.81) for systolic hypertension (>159 mmHg), 1.82 (1.12 to 2.98) for hyperuricemia (>6.29 mg/dl), 1.68 (1.02 to 2.77) for elevated body mass index (>24.9 kg/m2) compared with subjects with systolic BP <140 mmHg, serum uric acid <4.5 mg/dl, and body mass index 20.8 to 22.8 kg/m2. The rising prevalence of decreased kidney function in this population resulted mainly from the increasing prevalence of the risk factors in the population. Screening to detect decreased kidney function and early intervention to modify the associated risk factors should be considered in otherwise healthy individuals. Future studies are also necessary to determine whether implementation of these measures results in a reduction of ESRD incidence in the population.
This article has been cited by other articles:
![]() |
R. P. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer, and R. Klauser-Braun Elevated Uric Acid Increases the Risk for Kidney Disease J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2407 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Obermayr, C. Temml, M. Knechtelsdorfer, G. Gutjahr, J. Kletzmayr, S. Heiss, A. Ponholzer, S. Madersbacher, R. Oberbauer, and R. Klauser-Braun Predictors of new-onset decline in kidney function in a general middle-european population Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1265 - 1273. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673